We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Caliper Life Sciences and IntegenX Enter License Agreement for Microfluidics Patent Portfolio

News   Mar 11, 2011

 
Caliper Life Sciences and IntegenX Enter License Agreement for Microfluidics Patent Portfolio
 
 
 

RELATED ARTICLES

Blood Test May Enable Tailored Cystic Fibrosis Treatment

News

Study used blood test to identify distinct molecular signatures of disease; paves the way to precision medicine for cystic fibrosis.

READ MORE

Microfluidic Test Detects Those Ovulating, Based on Saliva Patterns

News

Advancements in microfluidics, artificial intelligence (AI) and the ubiquity of smartphones have lead to an ovulation testing tool that can automatically detect fern patterns - a marker of ovulation - in a saliva sample.

READ MORE

Immunotherapy Opportunities Lie in Glioma Molecular Landscape

News

A slow-growing brain tumor arising in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to immunotherapy, which gives the immune system a boost in fighting cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE